JP Morgan analyst Samik Chatterjee downgrades Ciena (NYSE:CIEN) from Overweight to Neutral and lowers the price target from $62 to $45.
Analyst Expectations for Harmony Biosciences’s Future
Analysts have provided the following ratings for Harmony Biosciences (NASDAQ:HRMY) within the last quarter: Bullish Somewhat Bullish Indifferent…